Minnesota House Bill HF2699

Minnesota 2025-2026 Regular Session

• Introduced: 3/24/25
• Refer: 3/24/25

Caption

Psilocybin cultivation, possession, transportation, and personal use by individuals 21 years of age or older authorized; protections established; public education and harm reduction programs established; Psychedelic Medicine Board established; criminal penalties provided; rulemaking authorized; civil actions authorized; and money appropriated.

Summary

HF2699 would legalize limited adult personal use of psilocybin in Minnesota for individuals age 21 and older. The bill permits adults to cultivate psilocybin mushrooms at their primary residence in a locked, enclosed space, possess and transport psilocybin up to a board-set possession limit, give it without payment to other adults within that limit, and use it in private residences or other private property not open to the public. It also states that no civil or criminal penalty may be imposed solely for those lawful activities. The bill does not create a commercial market for psilocybin. It expressly prohibits sale, commercial distribution, public use, use in motor vehicles on streets or highways, use on school grounds, use in correctional facilities, and use by persons under 21. It also creates minor offenses for underage possession/use within the limit and for certain prohibited uses, while preserving existing controlled-substance penalties for conduct outside the bill’s protections.

Impact

HF2699 would amend Minnesota’s controlled-substance statutes to carve out psilocybin from criminal and civil penalties for specified adult personal use, while leaving existing drug-crime provisions in place for trafficking, commercial distribution, and prohibited conduct. It would add new statutory sections in chapter 152 defining psilocybin, personal use, possession limits, and related terms, and it would establish a new Psychedelic Medicine Board to set possession limits, adopt rules, evaluate policy, and administer grants. The bill also directs the Department of Health to run public education, harm-reduction, and first-responder training programs, and it creates civil protections against discrimination in employment, housing, and custody/visitation decisions for lawful psilocybin use, with limited exceptions tied to federal law or safety.

Sentiment

Based on the bill text and the absence of recorded committee testimony or votes in the provided materials, the measure appears to be framed as a public-health and harm-reduction proposal rather than a punitive drug-enforcement bill. Its stated purpose is to reduce criminal-justice burdens and allow adults to make personal decisions about psilocybin without fear of prosecution. The overall tone of the legislation is permissive toward adult use, but it also includes safeguards and restrictions intended to address safety, youth access, and public-use concerns.

Contention

The main points of contention are likely to be the legalization of a psychedelic substance, the creation of a state board to regulate it, and the bill’s anti-discrimination protections. Supporters would likely emphasize harm reduction, adult autonomy, and reduced criminal-justice involvement, while opponents may object to normalizing psilocybin use, potential public-safety risks, and the costs of new education and administrative programs. The bill also leaves open important policy questions for the Psychedelic Medicine Board, including the possession limit and implementation details, which could be a source of debate.